Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Ding

Showing results (391-400 of 406) with videos related to

Pageof 41
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|October 9, 2024
Histone modifications of circulating nucleosomes are associated with changes in cell-free DNA fragmentation patternsJinyue Bai, Peiyong Jiang, Lu Ji, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 19, 2023
Fragmentation landscape of cell-free DNA revealed by deconvolutional analysis of end motifsZe Zhou, Mary-Jane L Ma, Rebecca W Y Chan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 6, 2024
Gemcitabine, carboplatin, and Epstein-Barr virus-specific autologous cytotoxic T lymphocytes for recurrent or metastatic nasopharyngeal carcinoma: VANCE, an international randomized phase III trialH C Toh, M-H Yang, H-M Wang, et al.
BMC Medicine|July 12, 2015
Intracoronary infusion of Wharton's jelly-derived mesenchymal stem cells in acute myocardial infarction: double-blind, randomized controlled trialLian R Gao, Yu Chen, Ning K Zhang, et al.
The Journal of Clinical Investigation|June 10, 2025
Patterns of intra- and inter-tumor phenotypic heterogeneity in lethal prostate cancerMartine P Roudier, Roman Gulati, Erolcan Sayar, et al.
Malaria Journal|April 7, 2017
Challenges for achieving safe and effective radical cure of Plasmodium vivax: a round table discussion of the APMEN Vivax Working GroupKamala Thriemer, Benedikt Ley, Albino Bobogare, et al.
Human Molecular Genetics|September 6, 2011
Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriersDavid G Cox, Jacques Simard, Daniel Sinnett, et al.
British Journal of Cancer|November 19, 2009
Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)A Osorio, R L Milne, G Pita, et al.
Human Molecular Genetics|August 7, 2009
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriersAntonis C Antoniou, Olga M Sinilnikova, Lesley McGuffog, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 26, 2012
A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriersYuan C Ding, Lesley McGuffog, Sue Healey, et al.
Pageof 41

Showing results (391-400 of 406) with videos related to

Sort By:
Pageof 41
Proceedings of the National Academy of Sciences of the United States of America|October 9, 2024
Histone modifications of circulating nucleosomes are associated with changes in cell-free DNA fragmentation patternsJinyue Bai, Peiyong Jiang, Lu Ji, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 19, 2023
Fragmentation landscape of cell-free DNA revealed by deconvolutional analysis of end motifsZe Zhou, Mary-Jane L Ma, Rebecca W Y Chan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 6, 2024
Gemcitabine, carboplatin, and Epstein-Barr virus-specific autologous cytotoxic T lymphocytes for recurrent or metastatic nasopharyngeal carcinoma: VANCE, an international randomized phase III trialH C Toh, M-H Yang, H-M Wang, et al.
BMC Medicine|July 12, 2015
Intracoronary infusion of Wharton's jelly-derived mesenchymal stem cells in acute myocardial infarction: double-blind, randomized controlled trialLian R Gao, Yu Chen, Ning K Zhang, et al.
The Journal of Clinical Investigation|June 10, 2025
Patterns of intra- and inter-tumor phenotypic heterogeneity in lethal prostate cancerMartine P Roudier, Roman Gulati, Erolcan Sayar, et al.
Malaria Journal|April 7, 2017
Challenges for achieving safe and effective radical cure of Plasmodium vivax: a round table discussion of the APMEN Vivax Working GroupKamala Thriemer, Benedikt Ley, Albino Bobogare, et al.
Human Molecular Genetics|September 6, 2011
Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriersDavid G Cox, Jacques Simard, Daniel Sinnett, et al.
British Journal of Cancer|November 19, 2009
Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)A Osorio, R L Milne, G Pita, et al.
Human Molecular Genetics|August 7, 2009
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriersAntonis C Antoniou, Olga M Sinilnikova, Lesley McGuffog, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 26, 2012
A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriersYuan C Ding, Lesley McGuffog, Sue Healey, et al.
Pageof 41